Literature DB >> 2221984

Lactate dehydrogenase release as an indicator of dithranol-induced membrane injury in cultured human keratinocytes. A time profile study.

B Bonnekoh1, B Farkas, J Geisel, G Mahrle.   

Abstract

HaCaT cells, a rapidly multiplying human keratinocyte line, were tested for their sensitivity to antipsoriatic dithranol with regard to classical proliferation parameters and for the drug's action on the plasma membrane integrity by the dose- and time-dependent release of cytosolic lactate dehydrogenase (LDH). In the case of 3H thymidine as well as 14C amino acid incorporation the 50% inhibition concentration (IC50) was 0.2 microM dithranol 24 h after initial exposure to the drug. For protein content of attached cells the IC50 proved to be greater than 3.0 microM. Using 0.3, 1.0 and 3.0 microM dithranol, significant (p less than 0.05) dose dependent LDH release of 0.866 +/- 0.387, 1.842 +/- 1.127 and 2.938 +/- 1.635 mU per hour and cm2 confluent culture area was measured between the 5th and the 24th hour, compared to an acetone control of 0.504 +/- 0.299 mU/h x cm2. Between the 2nd and the 4th hour as well as from the 25th to the 48th hour and the 49th to the 72nd hour the LDH release after dithranol treatment did not exceed the control value. In accordance with these findings dose-dependent morphological signs of cell injury were detected by phase contrast microscopy beyond the 4th hour. The data reveal that: HaCaT cells are a very sensitive target for the antiproliferative action of dithranol; the drug causes considerable plasma membrane damage even at concentrations as low as 0.3 microM; and this membrane damage becomes evident after a latency of at least 4 h and for a limited period of up to 24 h.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221984     DOI: 10.1007/bf00375727

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  30 in total

1.  The antipsoriatic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes.

Authors:  J Fuchs; W H Nitschmann; L Packer
Journal:  J Invest Dermatol       Date:  1990-01       Impact factor: 8.551

2.  Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.

Authors:  K U Schallreuter; M R Pittelkow
Journal:  Arch Dermatol       Date:  1987-11

3.  Skin toxicity and cellular metabolism: in vitro models.

Authors:  U Reichert
Journal:  Br J Dermatol       Date:  1986-08       Impact factor: 9.302

4.  A 'novel' action of anthralin.

Authors:  T Lotti; L Brunetti; E Panconesi
Journal:  Arch Dermatol       Date:  1986-07

5.  Autoradiographic in vitro-examination of psoriatic skin before, during and after dithranol treatment.

Authors:  G K Steigleder; H Schumann; K J Lennartz
Journal:  Arch Dermatol Forsch       Date:  1973

6.  Cytokinetic effects of anthralin on psoriatic keratinocytes.

Authors:  H Pullmann; K Enderer; G K Steigleder
Journal:  Br J Dermatol       Date:  1981-08       Impact factor: 9.302

7.  Epidermal cell culture systems in skin pharmacology.

Authors:  M Prunieras; C Delescluse
Journal:  Br J Dermatol       Date:  1984-07       Impact factor: 9.302

8.  [The effect of external antipsoriatic drugs on the cell respiration].

Authors:  W Raab; F Patermann
Journal:  Arch Klin Exp Dermatol       Date:  1966

9.  Inhibition of DNA replication and repair by anthralin or danthron in cultured human cells.

Authors:  J M Clark; P C Hanawalt
Journal:  J Invest Dermatol       Date:  1982-07       Impact factor: 8.551

10.  Formation of active oxygen species by dithranol, III. Dithranol, active oxygen species and lipid peroxidation in vivo.

Authors:  K Müller; W Wiegrebe; M Younes
Journal:  Arch Pharm (Weinheim)       Date:  1987-01       Impact factor: 3.751

View more
  5 in total

1.  The human keratinocyte cell line HaCaT: an in vitro cell culture model for keratinocyte testosterone metabolism.

Authors:  R Altenburger; T Kissel
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

2.  The effects of a novel herbal toothpaste on salivary lactate dehydrogenase as a measure of cellular integrity.

Authors:  Prem K Sreenivasan; Veera Venkata Prasad Kakarla; Shweta Sharda; Yogitha Setty
Journal:  Clin Oral Investig       Date:  2020-10-16       Impact factor: 3.573

3.  Repeated treatment with dithranol induces a tolerance reaction in keratinocytes in vitro.

Authors:  B Farkas; B Bonnekoh; G Mahrle
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes.

Authors:  L Hegemann; R Fruchtmann; B Bonnekoh; B H Schmidt; J Traber; G Mahrle; R Müller-Peddinghaus; L A van Rooijen
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

5.  The antipsoriatic drug, anthralin, inhibits protein kinase C--implications for its mechanism of action.

Authors:  L Hegemann; R Fruchtmann; L A van Rooijen; R Müller-Peddinghaus; G Mahrle
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.